FEBS Letters · 2001 · 191 citations · 16 references
Life SciencesCell BiologyOncologyApoptosisCancer PharmacologySteroid BiochemistryApoptosis In CancerApoptosis RegulationApoptotic SignalingAnticancer ActivityApoptosis InductionArachidonic Acid MetabolitesCell Cycle Arrest MechanismsG1 Cell-cycle ArrestGrowth FactorsNuclear Factor Kappa B ActivationP21 Regulation
Cyclooxygenases (COXs) are key enzymes in the conversion of arachidonic acid into prostanoids which are involved in apoptosis and inflammation. Two distinct COXs have been identified: COX-1 which is constitutively expressed and COX-2 which is induced by different products such as tumor promoters or growth factors. Previously, we demonstrated that a plant steroid, diosgenin, was a new megakaryocytic differentiation inducer of human erythroleukemia cells. In our study, we investigated the effect of diosgenin on the proliferation rate, cell cycle distribution and apoptosis in the human osteosarcoma 1547 cell line. The effects of this compound were also tested on COX expression and COX activities. Diosgenin treatment caused an inhibition of 1547 cell growth with a cycle arrest in G1 phase and apoptosis induction. Moreover, we found a correlation between p53, p21 mRNA expression and nuclear factor-kappaB activation and we observed a time-dependent increase in PGE2 synthesis after diosgenin treatment.
16
Role of NF-κB in p53-mediated programmed cell death
Kevin M. Ryan, Mary K. Ernst, Nancy R. Rice et al. · Nature · 2000 · 740 citations
Steven J. Shiff, Liang Qiao, Leo L. Tsai et al. · Journal of Clinical Investigation · 1995 · 414 citations · Full text
Medicine, Oncology, Pharmacology +17